World's Best Scientists 2026 revealed!
Kazuhiro Kakimi

Kazuhiro Kakimi

D-Index & Metrics

Immunology

D-Index
50
Citations
8813
World Ranking
4253
National Ranking
163

Kazuhiro Kakimi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazuhiro Kakimi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 267 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazuhiro Kakimi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuhiro Kakimi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazuhiro Kakimi is affiliated with Kindai University in Japan and has an extensive publication record centered around immunology, oncology, and cancer immunotherapy. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions specifically in Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery, and Molecular Biology.

The main topics of Kakimi's research focus on areas including Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, CAR-T cell therapy research, Immune cells in cancer, Gastric Cancer Management and Outcomes, and Monoclonal and Polyclonal Antibodies Research.

Selected recent publications illustrate their focus on tumor immunity and immunotherapeutic mechanisms:

  • Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape (2021, Science Immunology)
  • Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes (2021, Journal for ImmunoTherapy of Cancer)
  • Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations (2020, EBioMedicine)
  • Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody (2021, Liver Cancer)
  • Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy (2020, Journal for ImmunoTherapy of Cancer)

Kakimi frequently publishes work in specific academic venues including Cancer Research, Journal for ImmunoTherapy of Cancer, Regular and Young Investigator Award Abstracts, Nature Communications, and Scientific Reports.

Among frequent co-authors collaborating with Kakimi are Koji Nagaoka, Yukari Kobayashi, Hirokazu Matsushita, Yasuyuki Seto, and Jun Nakajima, indicating established research partnerships within the immunotherapy and oncology domains.

Best Publications

  • Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo

    Kazuhiro Kakimi;Luca G. Guidotti;Yasuhiko Koezuka;Francis V. Chisari

  • Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice

    Yasushi Sawanobori;Satoshi Ueha;Makoto Kurachi;Takeshi Shimaoka

  • Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes

    Kazuhiro Kakimi;Thomas E. Lane;Stefan Wieland;Valerie C. Asensio

  • Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

    Koji Kurose;Yoshihiro Ohue;Hisashi Wada;Shinsuke Iida

  • Interleukin-18 Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice

    Kiminori Kimura;Kazuhiro Kakimi;Stefan Wieland;Luca G. Guidotti

  • A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells

    Jun Nakajima;Tomohiro Murakawa;Takeshi Fukami;Shigenori Goto

  • Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration

    Makoto Kurachi;Junko Kurachi;Fumiko Suenaga;Tatsuya Tsukui

  • Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*

    M Kondo;K Sakuta;A Noguchi;N Ariyoshi

  • Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.

    Miki Sakamoto;Jun Nakajima;Tomohiro Murakawa;Takeshi Fukami

  • CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion

    Masanori Isogawa;Josan Chung;Yasuhiro Murata;Kazuhiro Kakimi

  • The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis

    Hirotake Tokuyama;Satoshi Ueha;Makoto Kurachi;Kouji Matsushima

  • Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections

    Kazuhiro Kakimi;Masanori Isogawa;JoSan Chung;Alessandro Sette

  • Activated Intrahepatic Antigen-Presenting Cells Inhibit Hepatitis B Virus Replication in the Liver of Transgenic Mice

    Kiminori Kimura;Kazuhiro Kakimi;Stefan Wieland;Luca G. Guidotti

  • An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer

    Takahiro Karasaki;Kazuhiro Nagayama;Hideki Kuwano;Jun-ichi Nitadori

  • Cutting Edge: Inhibition of Hepatitis B Virus Replication by Activated NK T Cells Does Not Require Inflammatory Cell Recruitment to the Liver

    Kazuhiro Kakimi;Thomas E. Lane;Francis V. Chisari;Luca G. Guidotti

  • Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells

    Grégoire Lauvau;Kazuhiro Kakimi;Gabriele Niedermann;Marina Ostankovitch

  • Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.

    Takeshi Kobayashi;Kazuhiro Kakimi;Eiichi Nakayama;Kowichi Jimbow

  • Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes.

    Giovanni Sitia;Masanori Isogawa;Kazuhiro Kakimi;Stefan F. Wieland

  • Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer

    Ikuo Wada;Hirokazu Matsushita;Shuichi Noji;Kazuhiko Mori

  • Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.

    Yoshiko Takeuchi;Tokiyoshi Tanegashima;Eiichi Sato;Takuma Irie

  • Dendritic cells for cancer immunotherapy

    Kazuhiro Kakimi;Atsushi Kondo;Hirokazu Matsushita

Frequent Co-Authors

Kouji Matsushima
Kouji Matsushima Tokyo University of Science
Francis V. Chisari
Francis V. Chisari Scripps Research Institute
Tatsuhiko Tsunoda
Tatsuhiko Tsunoda University of Tokyo
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo
Luca G. Guidotti
Luca G. Guidotti Vita-Salute San Raffaele University
Hiroyuki Aburatani
Hiroyuki Aburatani University of Tokyo
Osamu Ohara
Osamu Ohara Chiba University
Masashi Fukayama
Masashi Fukayama University of Tokyo
Hiroyoshi Nishikawa
Hiroyoshi Nishikawa Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various allied health and nursing career pathways. Many students interested in healthcare start by exploring programs like accelerated BSN programs for non nurses, which allow individuals without prior nursing experience to quickly enter the nursing profession.

For those looking for entry-level nursing roles, there are several accredited LPN programs easy to get into. These programs offer a solid foundation in patient care and serve as stepping stones toward more advanced qualifications.

Advancing further, students may consider nurse practitioner programs with easy admission. These programs provide specialized training, enabling graduates to take on greater responsibilities in clinical settings.

For those interested in mental health, enrolling in the best psychiatric mental health nurse practitioner programs online can be a great option. These programs combine flexibility and excellent clinical placement rates, making them ideal for students pursuing advanced nursing careers with a focus on mental health.

Best Scientists Citing Kazuhiro Kakimi

Trending Scientists

Recently Published Articles